Intrinsiqq
Acm Research Inc. logo

Acm Research Inc. (ACMR) Insider Trading

Last 12 months

Insiders sold $51.2M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. No executive or director has bought shares on the open market in the last two years.

Net open-market
−$51.2M
0 buys · 17 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
0 / 8
executives and directors
Last open-market buy
None
in the last two years

Get an email when ACMR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 8 – 910b5-1 plan
    David H Wang
    See Remarks · sold 140,000 at avg $75.93
    $10.6M
    7.6% of stake
  • Aug 2010b5-1 plan
    Mark McKechnie
    See Remarks · sold 55,199 at avg $77.27
    $4.26M
    98% of stake
  • Aug 1810b5-1 plan
    Haiping Dun
    Director · sold 5,000 at avg $81.13
    $406k
    0.6% of stake
  • Jun 4 – 510b5-1 plan
    Sotheara Cheav
    See remarks · sold 18,750 at avg $84.58
    $1.59M
    16% of stake
  • Jun 3 – 410b5-1 plan
    David H Wang
    See Remarks · sold 100,002 at avg $88.35
    $8.84M
    5.4% of stake
  • May 1910b5-1 plan
    Haiping Dun
    Director · sold 5,000 at avg $66.22
    $331k
    0.6% of stake
  • Apr 1710b5-1 plan
    Charles C Pappis
    Director · sold 5,000 at $52.00
    $260k
    100% of stake
  • Mar 1210b5-1 plan
    Mark McKechnie
    See Remarks · sold 98,551 at avg $45.58
    $4.49M
    99% of stake
  • Mar 11 – 1210b5-1 plan
    David H Wang
    See Remarks · sold 110,000 at avg $46.86
    $5.15M
    5.9% of stake
  • Mar 10 – 1110b5-1 plan
    Tracy Liu
    Director · sold 60,000 at avg $47.51
    $2.85M
    35% of stake
  • Mar 910b5-1 plan
    Haiping Dun
    Director · sold 5,000 at avg $43.47
    $217k
    0.6% of stake
  • Mar 5 – 610b5-1 plan
    Lisa Feng
    See remarks · sold 30,000 at avg $48.04
    $1.44M
    37% of stake
  • Mar 510b5-1 plan
    Charles C Pappis
    Director · sold 5,000 at $50.09
    $250k
    100% of stake
  • Dec 4, 2025 – Dec 8, 202510b5-1 plan
    Mark McKechnie
    See Remarks · sold 31,250 at avg $34.93
    $1.09M
    97% of stake
  • Dec 3, 2025 – Dec 4, 202510b5-1 plan
    David H Wang
    See Remarks · sold 130,000 at avg $33.55
    $4.36M
    6.9% of stake
  • Dec 2, 2025 – Dec 3, 202510b5-1 plan
    Fuping Chen
    See remarks · sold 120,000 at avg $33.18
    $3.98M
    100% of stake
  • Nov 12, 2025 – Nov 13, 202510b5-1 plan
    Lisa Feng
    See remarks · sold 30,000 at avg $33.27
    $998k
    37% of stake
  • Sep 18, 202510b5-1 plan
    Sotheara Cheav
    See remarks · sold 10,000 at $35.00
    $350k
    9.1% of stake
  • Sep 18, 202510b5-1 plan
    Jian Wang
    See remarks · sold 30,000 at $35.00
    $1.05M
    11% of stake
  • Sep 17, 202510b5-1 plan
    Tracy Liu
    Director · sold 15,000 at $33.00
    $495k
    12% of stake
  • Sep 3, 2025 – Sep 4, 202510b5-1 plan
    David H Wang
    See Remarks · sold 130,000 at avg $26.61
    $3.46M
    7.4% of stake
  • Aug 22, 2025 – Aug 25, 202510b5-1 plan
    Jian Wang
    See remarks · sold 60,000 at avg $31.00
    $1.86M
    19% of stake
  • Aug 22, 202510b5-1 plan
    Sotheara Cheav
    See remarks · sold 11,152 at $30.00
    $335k
    10% of stake
  • Jul 15, 202510b5-1 plan
    Tracy Liu
    Director · sold 15,000 at $30.00
    $450k
    12% of stake
  • Jul 7, 202510b5-1 plan
    Lisa Feng
    See remarks · sold 15,000 at $28.00
    $420k
    23% of stake
  • Jun 24, 202510b5-1 plan
    Lisa Feng
    See remarks · sold 15,000 at $26.00
    $390k
    23% of stake
  • May 21, 2025 – May 22, 202510b5-1 plan
    David H Wang
    See Remarks · sold 130,000 at avg $23.15
    $3.01M
    7.4% of stake
  • May 14, 202510b5-1 plan
    Mark McKechnie
    See Remarks · sold 15,000 at $25.22
    $378k
    94% of stake
  • Mar 17, 202510b5-1 plan
    Chenming Hu
    Director · sold 163,308 at $30.00
    $4.9M
    62% of stake
  • Mar 14, 202510b5-1 plan
    Haiping Dun
    Director · sold 9,518 at avg $29.00
    $276k
    1.1% of stake
  • Mar 11, 2025 – Mar 13, 202510b5-1 plan
    David H Wang
    See Remarks · sold 131,250 at avg $27.02
    $3.55M
    7.5% of stake
  • Mar 12, 202510b5-1 plan
    Mark McKechnie
    See Remarks · sold 15,000 at $27.42
    $411k
    94% of stake
  • Mar 10, 202510b5-1 plan
    Haiping Dun
    Director · sold 15,001 at $26.54
    $398k
    1.7% of stake
  • Feb 6, 202510b5-1 plan
    Sotheara Cheav
    See remarks · sold 22,598 at $23.00
    $520k
    18% of stake
  • Feb 6, 202510b5-1 plan
    Mark McKechnie
    See Remarks · sold 15,000 at $22.00
    $330k
    94% of stake
  • Nov 29, 202410b5-1 plan
    Haiping Dun
    Director · sold 19,058 at $17.43
    $332k
    2.2% of stake
  • Nov 29, 202410b5-1 plan
    David H Wang
    See Remarks · sold 56,250 at $17.44
    $981k
    3.5% of stake
  • Nov 26, 202410b5-1 plan
    David H Wang
    See Remarks · sold 56,250 at avg $17.89
    $1.01M
    3.4% of stake
  • Nov 22, 202410b5-1 plan
    Haiping Dun
    Director · sold 15,000 at $19.12
    $287k
    1.7% of stake
  • Nov 22, 202410b5-1 plan
    David H Wang
    See Remarks · sold 56,250 at $19.08
    $1.07M
    3.3% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ACMR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Special Industry Machinery, NEC

Spot a number that looks wrong? Check it in ACMR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ACMR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.